Abbott (NYSE:ABT) today announced two new clearances from the U.S. Food and Drug Administration (FDA) for the company’s industry-leading life support system. With the new indication, the CentriMag Blood Pump for use with the CentriMag™ System, is now cleared for longer-term use in adults when extracorporeal membrane oxygenation (ECMO) – a type of life support for people whose heart and lungs are not working – is critical to saving their life. Now, the clearance for longer-term support allows physicians more time to assess next steps and make critical care decisions for their patients.
Lucid Motors Stock Is Falling – What’s Going On?
Lucid Motors (NASDAQ: LCID) shares are falling on reports of the company looking to cut its workforce.
According to an internal memo, Lucid is reportedly planning to slash hundreds of employees to cut costs.
